On 26 April 2022, SFL’s CEO Shayesteh Fürst-Ladani will open the virtual multi-stakeholder workshop on ‘Market access for orphan drugs in Switzerland’ organized by the Rare Disease Action Forum (RDAF).

On the basis of a fictional case study, participants in the workshop will be given the opportunity to engage in discussions on the current framework for market access in Switzerland as well as to identify potential areas for improvement and solutions in a multi-stakeholder approach. This workshop aims to gather stakeholders from across the field of rare diseases: patient organizations, industry, research organizations, healthcare professionals, public authorities, decision makers and insurers.

Registration for the workshop is open.